Fără conexiune la internet — se afișează versiunea salvată a paginii.

IQVIA Holdings In…

USUSD
← Către Filtru
US:IQVLSE:0JDM

IQVIA Holdings Inc (LSE:0JDM) — Biotechnology: Commercial Physical & Biological Resarch. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.

Despre Companie

Site Web
iqvia.com
Relații cu Investitorii
ir.iqvia.com/
Sector
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Sediu Central
Durham, United States
Director General
Ari Bousbib
Angajați
94 000
Fondată
2016
Listată din
29.01.2018 (LSE:0JDM)
Acțiuni în Circulație
164.6 mil. la 2026-07-21
Free Float
156.25 mil.
Capitalizare de Piață
44.25 mld. USD
Insideri
1.09%
Investitori Instituționali
103.42%
Industrie (SIC)
Services-Commercial Physical & Biological Research
ISIN
US46266C1053
LEI
549300W3R20NM4KQPH86
P/E
47.1
Rata de Distribuire
41.0%
FCF
2.12 mld. USD
Plăți / FCF
27%
Datorie
15.8 mld. USD
6.6 ani FCF
Vechimea Dividendelor
—
Câștiguri, FCF și dividende plătite — pentru cele 12 luni până la 31.03.2026 (cel mai recent raport al companiei).
NAV
37.27 USD · P/NAV 7.00
Data Bilanțului31.03.2026
Active29.7 mld. USD
− Datorii23.3 mld. USD
= Capitalul Propriu Total6.35 mld. USD
− Interese Care Nu Controlează128 mil. USD
= NAV (capital propriu al acționarilor companiei)6.22 mld. USD
− Fond Comercial16.5 mld. USD
− Imobilizări Necorporale4.80 mld. USD
= NAV Tangibil−15.1 mld. USD
Acțiuni166 900 000
NAV pe Acțiune37.27 USD
NAV Tangibil pe Acțiune−90.63 USD
Prețul Acțiunii (0JDM)261.01 USD
P/NAV7.00
Istoricul NAV
Data BilanțuluiNAVNAV pe Acțiune
31.03.20266.22 mld. USD37.27 USD
31.12.20256.50 mld. USD38.34 USD
30.09.20256.16 mld. USD36.17 USD
30.06.20255.78 mld. USD33.99 USD
31.03.20255.98 mld. USD34.33 USD
31.12.20246.07 mld. USD34.45 USD
30.09.20246.97 mld. USD38.36 USD
30.06.20246.71 mld. USD36.83 USD
Descriere

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

publicitate

Burse și Simboluri

BursăSimbolMonedăPrețTip
US USA StocksIQV principalăUSD271.04 +3.45%acțiuni ordinare
LSE London Stock Exchange0JDM IOBUSD261.01 +0.00%acțiuni ordinare

Preț pe 3 Luni

zi de creștere zi de scădere data ex-dividend data plățiiTreceți cu mouse-ul / atingeți o zi — prețurile de deschidere, închidere, maxim și minim

Dividende

Nu s-au găsit plăți de dividende (verificat 19.10.2026). Probabil că societatea nu plătește dividende.

Știri din Această Săptămână

Comunicate de presă de pe site-ul investitorilor companiei, actualizate zilnic. Linkurile duc către site-ul companiei. Titlurile sunt în limba originală, ca pe site-ul companiei.

Cei Mai Mari Acționari

DeținătorParticipațieAcțiuniData Raportului
Blackrock Inc.8.84%14.55 mil.2026-06-30
Harris Associates L.P.7.4%12.18 mil.2026-06-30
Vanguard Capital Managem…6.63%10.91 mil.2026-06-30
State Street Corporation4.56%7.51 mil.2026-06-30
Vanguard Portfolio Manag…4.56%7.5 mil.2026-06-30
JPMORGAN CHASE & CO3.73%6.14 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…3.22%5.3 mil.2026-06-30
Artisan Partners Limited…2.88%4.74 mil.2026-06-30
Boston Partners2.71%4.47 mil.2026-06-30
Geode Capital Management…2.71%4.45 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.63%4.32 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.2%3.62 mil.2026-06-30
Invesco Ltd.1.99%3.28 mil.2026-06-30
HARRIS ASSOCIATES INVEST…1.58%2.61 mil.2026-06-30
HARRIS ASSOCIATES INVEST…1.56%2.57 mil.2026-06-30
iShares Trust-iShares Co…1.35%2.22 mil.2026-08-31
Fidelity Concord Street…1.31%2.16 mil.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.24%2.04 mil.2026-08-31
VANGUARD WINDSOR FUNDS-V…1.07%1.76 mil.2026-07-31
VANGUARD INDEX FUNDS-Van…0.96%1.59 mil.2026-06-30
BOUSBIB ARI B (Chief Exe…≈0.84%1.38 mil.2026-07-29
BRUEHLMAN RONALD E (Chie…≈0.03%55 9962026-02-06
HAAS BERND (Officer)≈0.01%24 4142026-02-06
GRENFELL ALISTAIR (Offic…≈0.01%24 1242026-02-06
SHERBET ERIC M (General…≈0.01%20 9992026-07-29
LEONARD JOHN M (Director…≈0.01%16 9462026-04-23
GOGGINS COLLEEN A (Direc…≈0.01%14 4532026-04-23
STAUB WALTER. RICHARD II…≈0.01%13 3122026-08-03
FEDOCK MICHAEL J. (Offic…≈0.01%9 5952026-02-06
DANHAKL JOHN G (Director…——2026-04-23